Intelligence · Clinical pipeline
Phase I Pipeline Programs
First-in-human and early clinical safety studies in Phase I.
Quick answer
NovaPharmaNews tracks 4,713 phase i pharmaceutical pipeline programs from ClinicalTrials.gov. First-in-human and early clinical safety studies in Phase I.
Top sponsors
- BRIGHT MINDS BIOSCIENCES 327 programs
- Takeda 276 programs
- Anaxis Pharma 204 programs
- Chinese Academy of 190 programs
- United Therapeutics Europe 184 programs
- Teva Pharma 154 programs
- First People's Hospital 149 programs
- Regeneron UK 126 programs
- Boehringer Ingelheim 94 programs
- Sunshine Guojian Pharmaceutical 85 programs
- Lakefront Biotherapeutics NV 62 programs
- HOFFMANN-LA ROCHE 58 programs
Pipeline programs
-
Cannabis sativa Extract
BRIGHT MINDS BIOSCIENCES INC.
Cannabis Dependence
1 trial -
Capivasertib
AstraZeneca
Advanced Solid Tumours
1 trial -
Carbamazepine
Aligos Therapeutics
Healthy Volunteer
1 trial -
Carbidopa
United Therapeutics Europe Ltd
Multiple Sclerosis
1 trial -
Carbon Monoxide inhalation
BRIGHT MINDS BIOSCIENCES INC.
Smoking
1 trial -
Cardiac Resynchronization Therapy
Rhythm Pharmaceuticals Netherlands B.V.
Heart Failure
1 trial -
Cardiovascular safety assessment of Tanimilast in healthy volunteers
Chiesi Farmaceutici S.p.A
This is Phase I study to assess the effect on the heart rate (HR) and cardiovascular safety according to electrocardiographic monitoring (including QT and QTc intervals) of CHF6001(Tanimilast) administered with NEXThaler® device in healthy adult volunteers.
1 trial -
Carfilzomib
ONCOLYTICS BIOTECH INC
Recurrent Plasma Cell Myeloma
1 trial -
Carfilzomib
Lxo Ireland Designated Activity Company
Acute Lymphoblastic Leukemia (ALL)
1 trial -
Carmustine
ADC Therapeutics SA
Recurrent Diffuse Large B-Cell Lymphoma
1 trial -
Carvedilol 25 mg tablets
Teva Pharma GmbH
Healthy
2 trials -
Casdatifan
Arcus Biosciences
Healthy Participants
3 trials -
Casirivimab and Imdevimab Antibody Cocktail
Regeneron UK Limited
COVID-19
1 trial -
Caveolin-1-Scaffolding-Protein-Derived Peptide (LTI-03)
Shanghai Reinovax Biologics Co.,LTD
Idiopathic Pulmonary Fibrosis
1 trial -
Cefadroxil 500 mg Capsules
Teva Pharma GmbH
Healthy
2 trials -
Cefdinir Capsules 300 mg
Teva Pharma GmbH
Healthy
2 trials -
Cefdinir for oral suspension 250 mg/5mL
Teva Pharma GmbH
Healthy
2 trials -
Cefprozil for oral suspension 250 mg/5 mL
Teva Pharma GmbH
Healthy
2 trials -
Ceftobiprole OATP1B interaction study
Lacuna Pharma Pty Ltd
Community-acquired bacterial pneumonia
1 trial -
Cefzil® 500 mg tablets
Teva Pharma GmbH
Healthy
1 trial -
Celecoxib
Akebia Europe Limited
Healthy Volunteers
1 trial -
Cell therapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Primary Ovarian Insufficiency
1 trial -
Cell therapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Periodontal Pocket
1 trial -
Cemiplimab
Regeneron UK Limited
Anaplastic Thyroid Cancer
1 trial -
Cemiplimab
Regeneron UK Limited
Locally Advanced Head and Neck Squamous Cell Carcinoma
1 trial -
Cemiplimab
Regeneron UK Limited
Advanced Malignancies
1 trial -
Cemiplimab
Regeneron UK Limited
Lung Cancer
1 trial -
Cemiplimab
Regeneron UK Limited
Epithelial Ovarian Cancer
1 trial -
Cemiplimab
Regeneron UK Limited
Hormone Receptor-positive Breast Cancer
1 trial -
Cemiplimab
Regeneron UK Limited
Advanced Cancer
1 trial -
Cemiplimab-Rwlc
Regeneron UK Limited
Merkel Cell Carcinoma
1 trial -
Cemsidomide
C4 Therapeutics
Multiple Myeloma (MM)
1 trial -
Ceralasertib
AstraZeneca
Advanced Solid Malignancies
1 trial -
Characterization of Immune Response in Participants from a Posdinemab Study
Janssen-Cilag International N.V.
Early Alzheimer's disease
1 trial -
Chemophase
HALOZYME THERAPEUTICS, INC.
Superficial Bladder Cancer
1 trial -
Chewing Gum
AXIM BIOTECHNOLOGIES, INC.
THC
1 trial -
Chimeric antigen receptor T cell
The First People's Hospital of Lianyungang
Pancreatic Cancer
1 trial -
Chinese Herbal Compound Ointment
The First People's Hospital of Lianyungang
Atrophic Vaginitis
1 trial -
Chinese tea flavor liquor
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Alcohols
1 trial -
Chlorhexidine
United Therapeutics Europe Ltd
Peri-Implantitis
1 trial -
Chloroquine
GlaxoSmithKline
Malaria
1 trial -
Chronocort
NEUROCRINE BIOSCIENCES INC
Adrenal Insufficiency
2 trials -
Ciforadenant
Corvus Pharmaceuticals
Multiple Myeloma
1 trial -
Ciforadenant
Corvus Pharmaceuticals
Renal Cell Cancer
1 trial -
Cigarette
BRIGHT MINDS BIOSCIENCES INC.
Cigarette Smoker
1 trial -
Cilostazol 100 mg tablets
Teva Pharma GmbH
Healthy
1 trial -
Cilostazol 50 mg Tablets
Teva Pharma GmbH
Healthy
1 trial -
Ciprofloxacin (Cipro InhaIe, BAYQ3939)
Bayer HealthCare AG
Pulmonary Disease, Chronic Obstructive
1 trial
Frequently asked questions
How many Phase I pipeline programs are in the directory?
4,713 published programs match this development stage in our ClinicalTrials.gov index.
What defines this pipeline stage?
Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.